Exploiting a new weakness in ‘zombie-like’ cells to treat senescence-associated diseases

The Rise of Senolytics: Targeting ‘Zombie Cells’ to Combat Cancer In the complex landscape of oncology, a latest frontier is emerging: the battle against senescent cells. Often described as ‘zombie cells,’ these are cells that have stopped dividing but refuse to die. Even as they might seem harmless because they don’t proliferate, they are far … Read more

Type 1 diabetes preserves fitness but alters oxygen use in teens

The Hidden Shift: Why “Normal” Fitness Isn’t the Whole Story For years, the benchmark for health in adolescents with type 1 diabetes has focused heavily on glycemic control and overall physical capacity. If a teenager can keep up with their peers on the soccer field or in the gym, it is often assumed that their … Read more

Revisiting memories together improves emotional wellbeing in dementia care

The Evolution of Dementia Care: Moving Toward Digital Reminiscence For many of the nearly 12 million Americans caring for loved ones with dementia, the experience is often described as losing someone who is still physically present. This phenomenon, known as pre-death grief, carries an emotional weight similar to post-death grief and can lead to profound … Read more

New gene therapy improves hearing in patients with rare genetic deafness

The Novel Frontier of Genetic Hearing Restoration The landscape of treating inherited deafness is shifting from managing hearing loss to potentially reversing it. Recent breakthroughs in gene therapy are demonstrating that it is possible to restore hearing in individuals born deaf, offering a glimpse into a future where genetic mutations no longer dictate a lifetime … Read more

Availability of HIV treatments contributed to a resurgence in syphilis

The Paradox of Progress: How HIV Breakthroughs Fueled a Syphilis Resurgence Medical history is often a series of trade-offs. One of the most significant breakthroughs in modern medicine—highly active antiretroviral therapy (HAART)—dramatically improved survival rates for those living with HIV starting in the late 1990s. However, a study published in Health Economics reveals a complex … Read more

Targeting glutamine metabolism enhances CAR-macrophage cancer therapy

The New Frontier of Immunotherapy: Fueling the Fight Against Solid Tumors For years, the promise of CAR-T cell therapy has transformed the treatment of blood cancers. Still, solid tumors have remained a stubborn fortress, protected by a hostile tumor microenvironment (TME) that effectively starves and exhausts immune cells. The latest breakthrough in metabolic engineering is … Read more

New study reveals CRISPR enzyme that responds to human DNA methylation

For decades, the “Holy Grail” of oncology has been a treatment that kills cancer cells while leaving healthy ones completely untouched. Chemotherapy, for all its success, remains a blunt instrument—a molecular sledgehammer that hits everything in its path, leading to the grueling side effects we’ve arrive to associate with cancer treatment. But we are entering … Read more

Chatty, leaky, and hardly human

The allure of a therapist who never sleeps, never judges, and costs a fraction of a traditional session is powerful. As we’ve seen with the surge in AI chatbot usage, millions are already turning to Large Language Models (LLMs) to navigate their darkest hours. But we are currently in the “Wild West” phase of digital … Read more

Liver cancer burden rising globally amid shift to metabolic risks

Organ Mutation Rates Explain Cancer Risk Differences

The Looming Liver Cancer Crisis: A Global Shift in Risk Factors Liver cancer remains a significant global health threat, ranking as the third leading cause of cancer-related deaths worldwide. In 2022 alone, nearly 870,000 new cases were reported, with hepatocellular carcinoma accounting for almost 80% of these. A concerning trend is emerging: even as progress … Read more

Prostate cancer patients recover faster with TULSA than robotic surgery

Minimally Invasive Prostate Cancer Treatment: A New Era of Faster Recovery? Men diagnosed with localized, intermediate-risk prostate cancer may soon have a new option that prioritizes a quicker return to daily life. A recent randomized clinical trial, presented at the 2026 Society of Interventional Radiology (SIR) Annual Scientific Meeting, suggests that MRI-guided, transurethral ultrasound ablation … Read more